Abstract:Background: There is significant heterogeneity in disease progression among hospitalized patients with COVID-19. The pathogenesis of SARS-CoV-2 infection is attributed to a complex interplay between virus and host immune response that in some patients unpredictably and rapidly leads to "hyperinflammation" associated with increased risk of mortality. The early identification of patients at risk of progression to hyperinflammation may help inform timely therapeutic decisions and lead to improved outcomes. Objective: The primary objective of this study was to use machine learning to reproducibly identify specific risk-stratifying clinical phenotypes across hospitalized patients with COVID-19 and compare treatment response characteristics and outcomes. A secondary objective was to derive a predictive phenotype classification model using routinely available early encounter data that may be useful in informing optimal COVID-19 bedside clinical management. Methods: This was a retrospective analysis of electronic health record data of adult patients (N=4379) who were admitted to a Johns Hopkins Health System hospital for COVID-19 treatment from 2020 to 2021. Phenotypes were identified by clustering 38 routine clinical observations recorded during inpatient care. To examine the reproducibility and validity of the derived phenotypes, patient data were randomly divided into 2 cohorts, and clustering analysis was performed independently for each cohort. A predictive phenotype classifier using the gradient-boosting machine method was derived using routine clinical observations recorded during the first 6 hours following admission. Results: A total of 2 phenotypes (designated as phenotype 1 and phenotype 2) were identified in patients admitted for COVID-19 in both the training and validation cohorts with similar distributions of features, correlations with biomarkers, treatments, comorbidities, and outcomes. In both the training and validation cohorts, phenotype-2 patients were older; had elevated markers of inflammation; and were at an increased risk of requiring intensive care unit-level care, developing sepsis, and mortality compared with phenotype-1 patients. The gradient-boosting machine phenotype prediction model yielded an area under the curve of 0.89 and a positive predictive value of 0.83. Conclusions: Using machine learning clustering, we identified and internally validated 2 clinical COVID-19 phenotypes with distinct treatment or response characteristics consistent with similar 2-phenotype models derived from other hospitalized populations with COVID-19, supporting the reliability and generalizability of these findings. COVID-19 phenotypes can be accurately identified using machine learning models based on readily available early encounter clinical data. A phenotype prediction model based on early encounter data may be clinically useful for timely bedside risk stratification and treatment personalization.

Automated Detection of Persistent Inflammatory Biomarkers in Post-COVID-19 Patients Using Machine Learning Techniques

Machine Learning-driven Analysis of Gastrointestinal Symptoms in Post-COVID-19 Patients

Unraveling Post-COVID-19 Immune Dysregulation Using Machine Learning-based Immunophenotyping

Early Detection of Post-COVID-19 Fatigue Syndrome Using Deep Learning Models

Characterizing Pulmonary Fibrosis Patterns in Post-COVID-19 Patients through Machine Learning Algorithms

Predicting Cardiovascular Complications in Post-COVID-19 Patients Using Data-Driven Machine Learning Models

Cognizance of Post-COVID-19 Multi-Organ Dysfunction through Machine Learning Analysis

Long-term Neurological Sequelae in Post-COVID-19 Patients: A Machine Learning Approach to Predict Outcomes

Predicting Long-term Renal Impairment in Post-COVID-19 Patients with Machine Learning Algorithms

Identifying Risk Factors for Post-COVID-19 Mental Health Disorders: A Machine Learning Perspective

Exploring post-COVID-19 health effects and features with advanced machine learning techniques

Machine Learning for Identifying Data-Driven Subphenotypes of Incident Post-Acute SARS-CoV-2 Infection Conditions with Large Scale Electronic Health Records: Findings from the RECOVER Initiative.

An artificial neural network classification method employing longitudinally monitored immune biomarkers to predict the clinical outcome of critically ill COVID-19 patients

Utilizing machine learning for survival analysis to identify risk factors for COVID-19 intensive care unit admission: A retrospective cohort study from the United Arab Emirates

Real-time infectious disease endurance indicator system for scientific decisions using machine learning and rapid data processing

Machine learning-based integration develops biomarkers initial the crosstalk between inflammation and immune in acute myocardial infarction patients

Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience

Comparative assessment of machine learning algorithms to predict severity of disease in COVID-19 patients based on eight cofactors

Identification and Prediction of Clinical Phenotypes in Hospitalized Patients With COVID-19: Machine Learning From Medical Records

Machine learning predictive modeling of the persistence of post-Covid19 disorders: Loss of smell and taste as case studies

Machine Learning Based Clinical Decision Support System for Early COVID-19 Mortality Prediction